X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
mutation (11) 11
female (10) 10
male (10) 10
lung cancer (8) 8
receptor, epidermal growth factor - genetics (8) 8
lung neoplasms (7) 7
lung neoplasms - genetics (7) 7
lung neoplasms - pathology (7) 7
middle aged (7) 7
oncology (7) 7
carcinoma, non-small-cell lung - genetics (6) 6
epidermal growth factor (6) 6
neoplasms. tumors. oncology. including cancer and carcinogens (6) 6
aged (5) 5
cancer therapies (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
chemotherapy (5) 5
egfr mutation analysis (5) 5
protein kinase inhibitors - therapeutic use (5) 5
survival analysis (5) 5
egfr (4) 4
lung neoplasms - drug therapy (4) 4
lung neoplasms - metabolism (4) 4
metastasis (4) 4
neoplasm staging (4) 4
pathology (4) 4
adenocarcinoma - pathology (3) 3
biopsy (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
deoxyribonucleic acid--dna (3) 3
dna mutational analysis - methods (3) 3
nsclc (3) 3
polymerase chain reaction (3) 3
prognosis (3) 3
respiratory system (3) 3
retrospective studies (3) 3
tumors (3) 3
adenocarcinoma - genetics (2) 2
adenocarcinoma - metabolism (2) 2
adult (2) 2
biomarkers, tumor - blood (2) 2
cancer (2) 2
carcinoma, non-small-cell lung - diagnosis (2) 2
carcinoma, non-small-cell lung - metabolism (2) 2
cell lung-cancer (2) 2
dna mutational analysis (2) 2
dna quality (2) 2
dna, neoplasm - genetics (2) 2
efficacy (2) 2
egfr-mutation-analysis (2) 2
erlotinib (2) 2
follow-up studies (2) 2
gene expression regulation, neoplastic (2) 2
immunohistochemistry (2) 2
kinases (2) 2
medicine & public health (2) 2
mutation - genetics (2) 2
protein kinase inhibitors - pharmacology (2) 2
receptor, epidermal growth factor - antagonists & inhibitors (2) 2
receptor, epidermal growth factor - metabolism (2) 2
respiratory tract diseases (2) 2
risk factors (2) 2
sensitivity and specificity (2) 2
squamous cell carcinoma (2) 2
thyroid nuclear factor 1 (2) 2
treatment outcome (2) 2
ttf-1 (2) 2
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma of lung (1) 1
adolescent (1) 1
age factors (1) 1
aged, 80 and over (1) 1
antigens (1) 1
antigens, neoplasm - blood (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
binding sites (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - genetics (1) 1
biopsy, fine-needle (1) 1
blood collection tubes (1) 1
brain cancer (1) 1
brain research (1) 1
c-kit (1) 1
ca-125 antigen - blood (1) 1
carcinoembryonic antigen - blood (1) 1
carcinoid (1) 1
carcinoma, non-small-cell lung - blood (1) 1
carcinoma, non-small-cell lung - chemistry (1) 1
carcinoma, non-small-cell lung - embryology (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, non-small-cell lung - surgery (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
cell morphological quality (1) 1
central nervous system metastases (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 06/2011, Volume 6, Issue 6, pp. 1039 - 1049
Journal Article
TumorDiagnostik & Therapie, ISSN 0722-219X, 2011, Volume 32, Issue 6, pp. 349 - 352
Journal Article
Oncology and therapy, ISSN 2366-1089, 2019, Volume 7, Issue 2, pp. 131 - 139
Precision medicine has revolutionized the understanding and treatment of cancer by identifying subsets of patients who are amenable to specific treatments... 
Internal Medicine | Medicine & Public Health | NSCLC | EGFR mutation analysis | Blood collection tubes | cfDNA | Mutation | Biopsy | Deoxyribonucleic acid--DNA | Shipping industry
Journal Article
International journal of clinical and experimental pathology, ISSN 1936-2625, 2016, Volume 9, Issue 5, pp. 5780 - 5786
Lung cancer is the leading cause of cancer-related mortality worldwide. The most common sites of lung cancer metastasis are the lymph nodes, brain, liver,... 
EGFR-TKI | EGFR mutation analysis | Gastrointestinal metastasis | Haplotype | Non-small cell lung cancer | haplotype | PHASE-II | PATHOLOGY | CANCER | TUMORS | CHALLENGES | HETEROGENEITY | gastrointestinal metastasis | ONCOLOGY | MUTATION | ERLOTINIB
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 10/2012, Volume 7, Issue 10, pp. 1522 - 1527
Journal Article
Journal Article
Zhongguo fei ai za zhi, ISSN 1009-3419, 09/2019, Volume 22, Issue 9, pp. 562 - 567
Background and objective EGFR-tyrosine kinase inhibitors (EGFR-TKIs) were used to treat non-small cell lung cancer (NSCLC) patients with EGFR mutation... 
Performance evaluation | Demography | Statistical analysis | Laboratories | Lung cancer | Mortality | Committees | Medical records | Metastasis | Cancer therapies | Meta-analysis | Studies | Survival analysis | Chemotherapy | Epidermal growth factor | Hospitals | Population | Mutation | Binding sites | Deoxyribonucleic acid--DNA | EGFR mutation positive | Tyrosine kinase inhibitors | Lung neoplasms
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.